RAB13 promotes diffuse large B-cell lymphoma progression and reduces lenalidomide sensitivity via PIK3CA-associated PI3K–AKT–mTOR signaling
Annals of Hematology · 21.08.2026 · 105 (12)
DOI: 10.1007/s00277-026-07229-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 21.08.2026. Verfasst von Bin Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Guizhou Medical University, The Affiliated Hospital of Guizhou Medical University, 28 Beijing Road, Guiyang, 550001, Guizhou…. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Class I Phosphatidylinositol 3-Kinases. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Program of the Science and Technology Department of Guizhou Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Guizhou Medical University, The Affiliated Hospital of Guizhou Medical University, 28 Beijing Road, Guiyang, 550001, Guizhou, P. R. China.
- Department of Pathology, Guizhou Medical University, The Affiliated Hospital of Guizhou Medical University, 28 Beijing Road, Guiyang, 550001, Guizhou, P. R. China. yangwenxiu4312@gmc.edu.cn.
- School of Clinical Medicine, Guizhou Medical University, Guiyang, 550001, Guizhou, P. R. China. yangwenxiu4312@gmc.edu.cn.
Förderung
- Key Research and Development Program of the Science and Technology Department of Guizhou Province
Zitieren
APA
Tang, B., Yang, W., Xu, D., Luo, Y., & Yang, W. (2026). RAB13 promotes diffuse large B-cell lymphoma progression and reduces lenalidomide sensitivity via PIK3CA-associated PI3K–AKT–mTOR signaling. Annals of Hematology, 105(12). https://doi.org/10.1007/s00277-026-07229-0
Vancouver
Tang B, Yang W, Xu D, Luo Y, Yang W. RAB13 promotes diffuse large B-cell lymphoma progression and reduces lenalidomide sensitivity via PIK3CA-associated PI3K–AKT–mTOR signaling. Annals of Hematology. 2026;105(12). doi:10.1007/s00277-026-07229-0
BibTeX
@article{Tang2026,
author = {Tang, Bin and Yang, Wen and Xu, Dan and Luo, Yun and Yang, Wenxiu},
title = {RAB13 promotes diffuse large B-cell lymphoma progression and reduces lenalidomide sensitivity via PIK3CA-associated PI3K–AKT–mTOR signaling},
journal = {Annals of Hematology},
year = {2026},
volume = {105},
number = {12},
doi = {10.1007/s00277-026-07229-0}
}
EUVIMED